The Humoral Response to HIV‐1: New Insights, Renewed Focus
Open Access
- 15 October 2010
- journal article
- review article
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 202 (S2), S315-S322
- https://doi.org/10.1086/655654
Abstract
During the past 2 decades, significant advances in our understanding of the humoral immune response to human immunodeficiency virus type 1 (HIV-1) infection have been made, yet a tremendous amount of work lies ahead. Despite these advances, strategies to reliably induce antibodies that can control HIV-1 infection are still critically needed. However, recent advances in our understanding of the kinetics, specificity, and function of early humoral responses offer alternative new approaches to attain this goal. These results, along with the new broadly neutralizing antibody specificities, the role for other antibody functions, the increased understanding of HIV-1-induced changes to B cell biology, and results from the RV144 “Thai” trial showing potential modest sterilizing protection by nonneutralizing antibody responses, have renewed focus on the humoral system. In this review, recent advances in our understanding of the earliest humoral responses are discussed, highlighting presentations from the meeting on the Biology of Acute HIV Infection.Keywords
This publication has 59 references indexed in Scilit:
- Broad Neutralization of Human Immunodeficiency Virus Type 1 Mediated by Plasma Antibodies against the gp41 Membrane Proximal External RegionJournal of Virology, 2009
- Limited Neutralizing Antibody Specificities Drive Neutralization Escape in Early HIV-1 Subtype C InfectionPLoS Pathogens, 2009
- In Vivo gp41 Antibodies Targeting the 2F5 Monoclonal Antibody Epitope Mediate Human Immunodeficiency Virus Type 1 Neutralization BreadthJournal of Virology, 2009
- The failed HIV Merck vaccine study: a step back or a launching point for future vaccine development?The Journal of Experimental Medicine, 2008
- Type-Specific Epitopes Targeted by Monoclonal Antibodies with Exceptionally Potent Neutralizing Activities for Selected Strains of Human Immunodeficiency Virus Type 1 Map to a Common Region of the V2 Domain of gp120 and Differ Only at Single Positions from the Clade B Consensus SequenceJournal of Virology, 2007
- Identification of a New Quaternary Neutralizing Epitope on Human Immunodeficiency Virus Type 1 Virus ParticlesJournal of Virology, 2005
- Interactions between Natural Killer Cells and Antibody Fc Result in Enhanced Antibody Neutralization of Human Immunodeficiency Virus Type 1Journal of Virology, 2005
- Antibody neutralization and escape by HIV-1Nature, 2003
- The mucosal immune system: primary target for HIV infection and AIDSTrends in Immunology, 2001
- Isolation of antigen‐binding cells from unprimed mice. II. Evidence for monospecificity of antigen‐binding cellsEuropean Journal of Immunology, 1976